Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MARCH6 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ACSL6 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GLRB - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ITGBL1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GRIK2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TSPYL1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
LMTK2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CTXN3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
EPHA4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
OLA1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CERS6 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GABARAPL1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SLC9A7 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PTER - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DLGAP1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RSPO2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SMARCA2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CD200 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
FNDC9 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on